310 related articles for article (PubMed ID: 11759282)
1. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss.
McMillan DC; Watson WS; O'Gorman P; Preston T; Scott HR; McArdle CS
Nutr Cancer; 2001; 39(2):210-3. PubMed ID: 11759282
[TBL] [Abstract][Full Text] [Related]
2. Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients.
O'Gorman P; McMillan DC; McArdle CS
Nutr Cancer; 1998; 32(2):76-80. PubMed ID: 9919615
[TBL] [Abstract][Full Text] [Related]
3. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones.
Simons JP; Schols AM; Buurman WA; Wouters EF
Clin Sci (Lond); 1999 Aug; 97(2):215-23. PubMed ID: 10409477
[TBL] [Abstract][Full Text] [Related]
4. Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer.
Elahi MM; McMillan DC; McArdle CS; Angerson WJ; Sattar N
Nutr Cancer; 2004; 48(2):171-3. PubMed ID: 15231451
[TBL] [Abstract][Full Text] [Related]
5. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer.
McMillan DC; Elahi MM; Sattar N; Angerson WJ; Johnstone J; McArdle CS
Nutr Cancer; 2001; 41(1-2):64-9. PubMed ID: 12094630
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin and the systemic inflammatory response in weight-losing patients with non-small cell lung cancer.
Jamieson NB; Brown DJ; Michael Wallace A; McMillan DC
Cytokine; 2004 Jul 21-Aug 7; 27(2-3):90-2. PubMed ID: 15242698
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients.
McMillan DC; Scott HR; Watson WS; Preston T; Milroy R; McArdle CS
Nutr Cancer; 1998; 31(2):101-5. PubMed ID: 9770720
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer.
O'Gorman P; McMillan DC; McArdle CS
Nutr Cancer; 1999; 35(2):127-9. PubMed ID: 10693165
[TBL] [Abstract][Full Text] [Related]
9. The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours.
McMillan DC; Talwar D; Sattar N; Underwood M; O'Reilly DS; McArdle C
Clin Nutr; 2002 Apr; 21(2):161-4. PubMed ID: 12056790
[TBL] [Abstract][Full Text] [Related]
10. Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer.
Barber MD; Ross JA; Fearon KC
Nutr Cancer; 1999; 35(2):106-10. PubMed ID: 10693162
[TBL] [Abstract][Full Text] [Related]
11. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.
Fouladiun M; Körner U; Bosaeus I; Daneryd P; Hyltander A; Lundholm KG
Cancer; 2005 May; 103(10):2189-98. PubMed ID: 15822132
[TBL] [Abstract][Full Text] [Related]
12. Performance status of male and female advanced cancer patients is independently predicted by mid-upper arm circumference measurement.
McMillan DC; Forrest LM; O'Gorman P; Angerson WJ; McArdle CS
Nutr Cancer; 2002; 42(2):191-3. PubMed ID: 12416259
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin as a marker of weight loss in lung cancer.
Karadag F; Gulen ST; Karul AB; Kilicarslan N; Ceylan E; Kuman NK; Cildag O
Scand J Clin Lab Invest; 2011 Dec; 71(8):690-4. PubMed ID: 22017168
[TBL] [Abstract][Full Text] [Related]
14. Circulating concentrations of "free" leptin in relation to fat mass and appetite in gastrointestinal cancer patients.
Wallace AM; Kelly A; Sattar N; McArdle CS; McMillan DC
Nutr Cancer; 2002; 44(2):157-60. PubMed ID: 12734062
[TBL] [Abstract][Full Text] [Related]
15. Lean body mass changes in cancer patients with weight loss.
Mcmillan DC; Watson WS; Preston T; Mcardle CS
Clin Nutr; 2000 Dec; 19(6):403-6. PubMed ID: 11104590
[TBL] [Abstract][Full Text] [Related]
16. Acute-phase reactants and plasma trace element concentrations in non-small cell lung cancer patients and controls.
Sattar N; Scott HR; McMillan DC; Talwar D; O'Reilly DS; Fell GS
Nutr Cancer; 1997; 28(3):308-12. PubMed ID: 9343841
[TBL] [Abstract][Full Text] [Related]
17. Plasma lyso-phosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory status.
Taylor LA; Arends J; Hodina AK; Unger C; Massing U
Lipids Health Dis; 2007 Jul; 6():17. PubMed ID: 17623088
[TBL] [Abstract][Full Text] [Related]
18. [Nutritional status, comorbidity, and inflammation in hemodialysis].
Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Vázquez A
Nefrologia; 2000; 20(6):540-9. PubMed ID: 11217649
[TBL] [Abstract][Full Text] [Related]
19. The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases.
Al-Shaiba R; McMillan DC; Angerson WJ; Leen E; McArdle CS; Horgan P
Br J Cancer; 2004 Jul; 91(2):205-7. PubMed ID: 15213726
[TBL] [Abstract][Full Text] [Related]
20. Nutritional status, systemic inflammation and prognosis of patients with gastrointestinal cancer.
Gomes de Lima KV; Maio R
Nutr Hosp; 2012; 27(3):707-14. PubMed ID: 23114934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
